FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases

FOLFIRINOX is a standard chemotherapeutic regimen for patients with advanced pancreatic cancer who have a good performance status. In this study, we present the case of a 64-year-old male who developed dysarthria following FOLFIRINOX treatment, and review all four cases of dysarthria encountered amo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: MATSUOKA, AYUMU, MAEDA, OSAMU, INADA-INOUE, MEGUMI, OHNO, EIZABURO, HIROOKA, YOSHIKI, YOKOYAMA, YUKIHIRO, FUJII, TSUTOMU, NAGINO, MASATO, GOTO, HIDEMI, ANDO, YUICHI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4579986/
https://ncbi.nlm.nih.gov/pubmed/26622908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados